Bionic eyes: outdated tech leaves patients in the dark
Bionic Eyes are called Outdated Technology and patients who have retinal implants that are dependent on are now obsolete.
Second Sight Company used to made bionic eyes has stopped making its Argus II bionic eyes several years ago and now focusing on brain implantation.
As per the IEEE spectrum, it is now hoping to merge with a biopharmaceutical firm that is not used to make the implant.
Highlights
- Second Sight’s Website is developing technology to enhance the lives of blinds.
- Technology is not cheap, it cost about $150,000 excluding surgery and post-surgery training.
- Many patient and technology users are not happy with Second Sight technology.
Read More: New 'Air Taxis' could take you into the sky without a pilot
Bionic eyes technology is obsolete now and many stories are witnessing the technology is leaving the users in dark. As per the IEEE Spectrum, a merger will happen with a biopharmaceutical firm that does not make implants.
Second Sight is a company that used to make such Bionic technology eyes and as per the website its Argus II offers life-changing benefits for those with sight impairments and also includes “Enjoying mobility and independence.”
Adam Mendelsohn is the chief executive of Nano Precision Medical is a company with which Second Sight has a plan to merge, stated as “I do intend to make this one our priorities if and when I assume my leadership position in the combined company,” Mendelsohn said while answering to BBC.
Second Sight Company stopped developing such bionic eyes, said “our mission is to develop neuro-stimulation technology to enhance the lives of blind individuals while supporting our current users,” it stated.
It also told the company is now planning to implant brain and hence discontinued developing bionic eyes.
The company develop a technology that is said to give an enhancement for the patients with blind eyes, the technology is not cheap and hence mediocre people can’t afford it. It has taken a decade to develop the technology and is not cheap, it charges around $150,000 excluding surgery and post-surgery training.
Patients who have used the technology are not satisfied with the technology and hence they are making it a huge concern for others.
One, Ross Doerr told the company Second Sight failed to connect with its patients after its financial difficulty in 2020. He further stated, “those of us with the implant are figuratively and literally in the dark.”
Jeroen Perk, a Second Sight user said he had problems when his VPU system broke in November 2020, “I had no vision, no Argus, and no support from Second Sight,” he said such to the publication.
